19-8364441-G-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_139314.3(ANGPTL4):​c.120G>T​(p.Glu40Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000712 in 1,403,582 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E40K) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.1e-7 ( 0 hom. )

Consequence

ANGPTL4
NM_139314.3 missense

Scores

1
17

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.61

Publications

0 publications found
Variant links:
Genes affected
ANGPTL4 (HGNC:16039): (angiopoietin like 4) This gene encodes a glycosylated, secreted protein containing a C-terminal fibrinogen domain. The encoded protein is induced by peroxisome proliferation activators and functions as a serum hormone that regulates glucose homeostasis, lipid metabolism, and insulin sensitivity. This protein can also act as an apoptosis survival factor for vascular endothelial cells and can prevent metastasis by inhibiting vascular growth and tumor cell invasion. The C-terminal domain may be proteolytically-cleaved from the full-length secreted protein. Decreased expression of this gene has been associated with type 2 diabetes. Alternative splicing results in multiple transcript variants. This gene was previously referred to as ANGPTL2 but has been renamed ANGPTL4. [provided by RefSeq, Sep 2013]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07844725).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_139314.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANGPTL4
NM_139314.3
MANE Select
c.120G>Tp.Glu40Asp
missense
Exon 1 of 7NP_647475.1Q9BY76-1
ANGPTL4
NM_001039667.3
c.120G>Tp.Glu40Asp
missense
Exon 1 of 6NP_001034756.1Q9BY76-2
ANGPTL4
NR_104213.2
n.287G>T
non_coding_transcript_exon
Exon 1 of 3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANGPTL4
ENST00000301455.7
TSL:1 MANE Select
c.120G>Tp.Glu40Asp
missense
Exon 1 of 7ENSP00000301455.1Q9BY76-1
ANGPTL4
ENST00000593998.5
TSL:1
n.120G>T
non_coding_transcript_exon
Exon 1 of 8ENSP00000472551.1Q9BY76-1
ANGPTL4
ENST00000955923.1
c.120G>Tp.Glu40Asp
missense
Exon 2 of 8ENSP00000625982.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
7.12e-7
AC:
1
AN:
1403582
Hom.:
0
Cov.:
32
AF XY:
0.00000144
AC XY:
1
AN XY:
693506
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
32374
American (AMR)
AF:
0.00
AC:
0
AN:
36524
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25214
East Asian (EAS)
AF:
0.0000272
AC:
1
AN:
36812
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79922
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
44694
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5358
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1084382
Other (OTH)
AF:
0.00
AC:
0
AN:
58302
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.225
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
21
DANN
Benign
0.96
DEOGEN2
Benign
0.0093
T
Eigen
Benign
-0.41
Eigen_PC
Benign
-0.23
FATHMM_MKL
Benign
0.75
D
LIST_S2
Benign
0.85
T
M_CAP
Benign
0.079
D
MetaRNN
Benign
0.078
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.1
L
PhyloP100
1.6
PrimateAI
Uncertain
0.76
T
PROVEAN
Benign
0.26
N
REVEL
Benign
0.041
Sift
Benign
0.99
T
Sift4G
Benign
0.36
T
Polyphen
0.18
B
Vest4
0.17
MutPred
0.21
Gain of catalytic residue at A36 (P = 0.2404)
MVP
0.60
MPC
0.72
ClinPred
0.61
D
GERP RS
3.9
PromoterAI
0.0033
Neutral
Varity_R
0.14
gMVP
0.45
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs780654441; hg19: chr19-8429325; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.